Abstract
In order to achieve a high efficacy in cancer therapies which use radiation and/or hyperthermia, it is necessary to study and understand two important signal transduction pathways which can depress cell survival signals and simultaneously enhance cell death signals. Recent progress in molecular biology has provided information about these molecules and the associated mechanisms involved in their signaling and functioning. Targeting therapies have thus been examined to look for those which can affect genes capable of inducing a high efficiency in killing cancer cells after exposures to radiation and/or hyperthermia therapies. Target genes which function in cell survival signal transduction pathways, DNA repair, and protein repair are of primary interest. In contrast, apoptosis- and necrosis-inducing factors have an important role in leading to cell death in response to therapies. In this review, results from recent research efforts in Nara University are discussed.
Keywords: p53, signal transduction, radiation, hyperthermia, cancer therapy
Current Signal Transduction Therapy
Title: Signal Transduction of Radiation and/or Hyperthermic Cancer Therapies
Volume: 5 Issue: 3
Author(s): Takeo Ohnishi and Akihisa Takahashi
Affiliation:
Keywords: p53, signal transduction, radiation, hyperthermia, cancer therapy
Abstract: In order to achieve a high efficacy in cancer therapies which use radiation and/or hyperthermia, it is necessary to study and understand two important signal transduction pathways which can depress cell survival signals and simultaneously enhance cell death signals. Recent progress in molecular biology has provided information about these molecules and the associated mechanisms involved in their signaling and functioning. Targeting therapies have thus been examined to look for those which can affect genes capable of inducing a high efficiency in killing cancer cells after exposures to radiation and/or hyperthermia therapies. Target genes which function in cell survival signal transduction pathways, DNA repair, and protein repair are of primary interest. In contrast, apoptosis- and necrosis-inducing factors have an important role in leading to cell death in response to therapies. In this review, results from recent research efforts in Nara University are discussed.
Export Options
About this article
Cite this article as:
Ohnishi Takeo and Takahashi Akihisa, Signal Transduction of Radiation and/or Hyperthermic Cancer Therapies, Current Signal Transduction Therapy 2010; 5 (3) . https://dx.doi.org/10.2174/157436210791920283
DOI https://dx.doi.org/10.2174/157436210791920283 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ruthenium Complexes as Anticancer Agents
Current Medicinal Chemistry COX-2 and Colorectal Cancer
Current Pharmaceutical Design Attenuation of ERK/RSK2-Driven NFκB Gene Expression and Cancer Cell Proliferation by Kurarinone, a Lavandulyl Flavanone Isolated from Sophora flavescens Ait. Roots
Endocrine, Metabolic & Immune Disorders - Drug Targets Angiogenesis Inhibitors: Perspectives for Medical, Surgical and Radiation Oncology
Current Pharmaceutical Design How to Make a Non-Antigenic Protein (Auto) Antigenic: Molecular Complementarity Alters Antigen Processing and Activates Adaptive-Innate Immunity Synergy
Anti-Cancer Agents in Medicinal Chemistry Cytotoxicity of Novel Sulfanilamides Towards Sensitive and Multidrugresistant Leukemia Cells
Current Medicinal Chemistry Current and Experimental Antibody-Based Therapeutics: Insights, Breakthroughs, Setbacks and Future Directions
Current Molecular Medicine Toxicities of Targeted Agents in Advanced Renal Cell Carcinoma
Current Clinical Pharmacology Targeted Cancer Therapy; Nanotechnology Approaches for Overcoming Drug Resistance
Current Medicinal Chemistry MDA-7/IL-24-Based Cancer Gene Therapy: Translation from the Laboratory to the Clinic
Current Gene Therapy Focal Adhesion Kinase as a Cancer Therapy Target
Anti-Cancer Agents in Medicinal Chemistry Serine Proteinase Inhibitors in the Skin: Role in Homeostasis and Disease
Current Protein & Peptide Science Image Fusion Based on Estimation Theory: Applied to PET/CT for Radiotherapy
Recent Patents on Medical Imaging Studies on Anticancer Activities of Lactoferrin and Lactoferricin
Current Protein & Peptide Science Clinical Trials with Oncolytic Adenovirus in China
Current Cancer Drug Targets Amniotic Fluid Stem Cells: a Promising Therapeutic Resource for Cell-Based Regenerative Therapy
Current Pharmaceutical Design Oncolytic Viruses: Programmable Tumour Hunters
Current Gene Therapy Monoclonal Antibody-Based Targeted Therapy in Breast Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Radiofluorinated Carbohydrates for Positron Emission Tomography
Current Topics in Medicinal Chemistry Self-Assembly of DNA and Cell-Adhesive Proteins onto pH-Sensitive Inorganic Crystals for Precise and Efficient Transgene Delivery
Current Pharmaceutical Design